Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ModivCare IncMODV · Entity 76927 | Director | February 14, 2024 | February 16, 2024 |
| Science Applications International CorpSAIC · Entity 3870 | Director | June 04, 2025 | June 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ModivCare Inc
Report date February 14, 2024 · Filed February 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,844 |
Reported balance
After 2024-02-14 transaction · row 1
1 source rowRow 1 · 2024-02-14 · Grant · Acquired 2,658 · Balance 5,844 F1: Represents restricted shares scheduled to fully vest on February 14, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares scheduled to fully vest on February 14, 2025.
Science Applications International Corp
Report date June 04, 2025 · Filed June 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,803 |
Reported balance
After 2025-06-04 transaction · row 1
1 source rowRow 1 · 2025-06-04 · Grant · Acquired 1,644 · Balance 8,803 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2025 Filed Jun 5, 2025 16:44 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 1,644 | $103.43 | $170,038.92 |
DisclosureSEC source: 0001571123-25-000133 · wk-form4_1749156061.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,803 Read SEC document |
| April 14, 2025 Filed Apr 14, 2025 16:36 UTC | Science Applications International Corp SAIC · Entity 3870 | PurchaseCommon Stock | 215 | $116.75 | $25,101.47 |
DisclosureSEC source: 0001571123-25-000086 · wk-form4_1744662953.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,159 Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 16:03 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 1,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001571123-24-000092 · wk-form4_1717704209.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,944 Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:34 UTC | ModivCare Inc MODV · Entity 76927 | GrantCommon Stock | 2,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004595 · rdgdoc.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,844 F1 · shares: Represents restricted shares scheduled to fully vest on February 14, 2025. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 16:42 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001571123-23-000095 · wk-form4_1686256924.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,493 Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 16:18 UTC | ModivCare Inc MODV · Entity 76927 | GrantCommon Stock | 1,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-003980 · rdgdoc.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,186 F1 · shares: Represents restricted shares scheduled to fully vest on February 16, 2024. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 16:04 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001571123-22-000034 · wf-form4_165480508055273.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,893 Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 20:24 UTC | ModivCare Inc MODV · Entity 76927 | GrantCommon Stock | 1,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-002924 · rdgdoc.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,872 Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:02 UTC | Science Applications International Corp SAIC · Entity 3870 | GrantCommon Stock | 2,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-008876 · doc4.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,151 Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 17:44 UTC | ModivCare Inc MODV · Entity 76927 | GrantCommon Stock | 649 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-010504 · rdgdoc.xml · nonDerivative · entry 1 Graham Garth · CIK 0001851096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.